Michael Neuberger (1953–2013)

See allHide authors and affiliations

Science  13 Dec 2013:
Vol. 342, Issue 6164, pp. 1335
DOI: 10.1126/science.1248808

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Michael Samuel Neuberger, the brilliant molecular biologist whose work stimulated the development of therapeutic antibodies and transformed our understanding of antibody diversification, died in Cambridge, UK, on 26 October from myeloma (a cancer of antibody-producing B cells), a week before his 60th birthday. Michael was the first to recognize this irony, writing after his diagnosis, “So after 35 years of tormenting antibodies in the lab, they are now getting their own back on me in the clinic.”